A message from Charles Gillies
Chairman of the HumanWare Board

November 13, 2007

Christchurch, New Zealand - "As part of the ongoing development and growth of HumanWare in global markets and in order to execute long term strategic plans, the Board has determined that a number of key decision making roles, including that of chief executive officer, will be based in North America. In part this will ensure that HumanWare remains close to market trends, distributors, key customers and partners.

HumanWare's current CEO, Dr Richard Mander, is committed to remaining in New Zealand, and as a result the Board has with regret accepted his resignation.

Board Chairman Charles Gillies, said "I take this opportunity to thank Dr Mander for the energy and commitment he has given to his position and wish him well in his future work. Dr Mander has guided HumanWare through a period of significant change and achievement. In particular Dr Mander's skills in technology and product development have kept HumanWare at the forefront of the industry and positioned HumanWare for the next step in its growth. Given Dr Mander's diverse work experiences, I know he will contribute greatly to whatever role he takes in the future".

The Board is pleased to announce that the CEO of HumanWare is Gilles Pepin.

He will be available to answer questions in the coming days."

Regards
Charles Gillies
Chairman of the HumanWare Board

 

Managing Partner
Jolimont Capital Pty Ltd
ACN 104 741 237
Level 1, 133 Flinders Lane
Melbourne Victoria 3000 Australia
P O Box 376
Flinders Lane Vic 8009
p +61 3 9038 8808
m + 61 412 120 452
f + 61 3 9639 5228
e charlesg@jolimontcapital.com.au